These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 28448581
1. The performance of BD FACSPresto™ for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia. Gebremicael G, Belay Y, Girma F, Abreha Y, Gebreegziabxier A, Tesfaye S, Messele Z, Assefa Y, Bellete B, Kassa D, Vojnov L. PLoS One; 2017; 12(4):e0176323. PubMed ID: 28448581 [Abstract] [Full Text] [Related]
2. Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria. Negedu-Momoh OR, Jegede FE, Yakubu A, Balogun O, Abdullahi M, Badru T, Oladele EA, Agbakwuru C, Khamofu H, Torpey K. PLoS One; 2017; 12(5):e0178037. PubMed ID: 28542359 [Abstract] [Full Text] [Related]
3. Clinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in Kenya. Angira F, Akoth B, Omolo P, Opollo V, Bornheimer S, Judge K, Tilahun H, Lu B, Omana-Zapata I, Zeh C. PLoS One; 2016; 11(8):e0157939. PubMed ID: 27483008 [Abstract] [Full Text] [Related]
4. Performance of the BD-FACS Presto for CD4 count and hemoglobin measurement in a district hospital and rural laboratory in Ghana. Moran Z, Sacks JA, Frimpong FK, Frimpong AB, Ben Amor Y. PLoS One; 2019; 14(2):e0212684. PubMed ID: 30794637 [Abstract] [Full Text] [Related]
5. Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa. Coetzee LM, Moodley K, Glencross DK. PLoS One; 2016; 11(5):e0156266. PubMed ID: 27224025 [Abstract] [Full Text] [Related]
6. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya. Zeh C, Rose CE, Inzaule S, Desai MA, Otieno F, Humwa F, Akoth B, Omolo P, Chen RT, Kebede Y, Samandari T. J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048 [Abstract] [Full Text] [Related]
7. Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis. Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S. BMC Infect Dis; 2016 Oct 21; 16(1):592. PubMed ID: 27769181 [Abstract] [Full Text] [Related]
8. Performance Evaluation of the MyT4 Technology for Determining ART Eligibility. Sitoe N, Macamo R, Meggi B, Tobaiwa O, Loquiha O, Bollinger T, Vojnov L, Jani I. PLoS One; 2016 Oct 21; 11(10):e0165163. PubMed ID: 27780216 [Abstract] [Full Text] [Related]
9. The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+ T Cell Counts. Bwana P, Vojnov L, Adhiambo M, Akinyi C, Mwende J, Prescott M, Mwau M. PLoS One; 2015 Oct 21; 10(12):e0145586. PubMed ID: 26720601 [Abstract] [Full Text] [Related]
14. A meta-analysis of the performance of the Pima™ CD4 for point of care testing. Scott LE, Campbell J, Westerman L, Kestens L, Vojnov L, Kohastsu L, Nkengasong J, Peter T, Stevens W. BMC Med; 2015 Jul 25; 13():168. PubMed ID: 26208867 [Abstract] [Full Text] [Related]
15. Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection. Makadzange AT, Bogezi C, Boyd K, Gumbo A, Mukura D, Matubu A, Ndhlovu CE. PLoS One; 2016 Jul 25; 11(7):e0157546. PubMed ID: 27388763 [Abstract] [Full Text] [Related]